Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Merkel Cell × High-Energy Shock Waves × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 3 Triple Negative Breast Neoplasms 1 Thyroid Cancer, Papillary 1 Stage I Mixed Cell Type Kidney Wilms Tumor 1 Prostatic Neoplasms 1 Pleuropulmonary blastoma 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neuroblastoma 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Hairy Cell 1 Ganglioneuroblastoma 1 Endometrial Neoplasms 1 Duodenal Neoplasms 1 Anatomic Stage IV Breast Cancer AJCC v8 1 Anatomic Stage III Breast Cancer AJCC v8 1 Anatomic Stage II Breast Cancer AJCC v8 1 Anatomic Stage I Breast Cancer AJCC v8 1 Agnosia 1 Adenocarcinoma, Follicular 1

Interventions

Nivolumab 8 pembrolizumab 7 avelumab 5 Specimen Handling 5 Biopsy 5 Magnetic Resonance Spectroscopy 4 Ipilimumab 4 cemiplimab 2 atezolizumab 2 aldesleukin 2 Radiotherapy 2 Immunoglobulin G 2 Cyclophosphamide 2 Bevacizumab 2 tocilizumab 1 talimogene laherparepvec 1 sargramostim 1 relatlimab 1 regorafenib 1 prednylidene 1 poly ICLC 1 fludarabine phosphate 1 fludarabine 1 flt3 ligand protein 1 durvalumab 1 deltacortene 1 decitabine and cedazuridine drug combination 1 aflibercept 1 X-Rays 1 Sirolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡